Takeda Given More Time To File Certiorari Petition In TPP Class Certification Case
WASHINGTON, D.C. — The U.S. Supreme Court granted the manufacturer of the diabetes drug Actos more time to file its petition for a writ of certiorari to challenge a Ninth Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article